Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial - PubMed (original) (raw)
Randomized Controlled Trial
Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial
Elizabeth L Barry et al. JAMA Oncol. 2017.
Abstract
Importance: Despite epidemiological and preclinical evidence suggesting that vitamin D and calcium inhibit colorectal carcinogenesis, daily supplementation with these nutrients for 3 to 5 years was not found to significantly reduce the risk of recurrent colorectal adenomas in a recent randomized clinical trial.
Objective: To investigate whether common variants in 7 vitamin D and calcium pathway genes (VDR, GC, DHCR7, CYP2R1, CYP27B1, CYP24A1, and CASR) modify the effects of vitamin D3 or calcium supplementation on colorectal adenoma recurrence.
Design, setting, and participants: We examined 41 candidate single-nucleotide polymorphisms (SNPs) in 2259 participants in a randomized, double-blind, placebo-controlled trial conducted at 11 clinical centers in the United States. Eligibility criteria included a recently diagnosed adenoma and no remaining colorectal polyps after complete colonoscopy. The study's treatment phase ended on August 31, 2013, and the analysis for the present study took place from July 28, 2014, to October 19, 2016.
Interventions: Daily oral supplementation with vitamin D3 (1000 IU) or calcium carbonate (1200 mg elemental calcium) or both or neither.
Main outcomes and measures: The outcomes assessed were the occurrence of 1 or more adenomas or advanced adenomas (estimated diameter, ≥1 cm; or with villous histologic findings, high-grade dysplasia, or cancer) during follow-up. Treatment effects and genotype associations and interactions were estimated as adjusted risk ratios (RRs) and 95% confidence intervals (CIs). The effective number of independent SNPs was calculated to correct for multiple testing.
Results: Among the 2259 participants randomized, 1702 were non-Hispanic whites who completed the trial and had genotype data for analysis (1101 men; mean [SD] age 58.1 [6.8] years). The effect of vitamin D3 supplementation on advanced adenomas, but not on adenoma risk overall, significantly varied according to genotype at 2 VDR SNPs (rs7968585 and rs731236) in linkage disequilibrium (D' = 0.98; r2 = 0.6). For rs7968585, among individuals with the AA genotype (26%), vitamin D3 supplementation reduced risk by 64% (RR, 0.36; 95% CI, 0.19-0.69; P = .002; absolute risk decreased from 14.4% to 5.1%). Among individuals with 1 or 2 G alleles (74%), vitamin D3 supplementation increased risk by 41% (RR, 1.41; 95% CI, 0.99-2.00; P = .05; absolute risk increased from 7.7% to 11.1%; P < .001 for interaction). There were no significant interactions of genotypes with calcium supplementation.
Conclusions and relevance: Our findings suggest that benefits from vitamin D3 supplementation for the prevention of advanced colorectal adenomas may vary according to vitamin D receptor genotype.
Trial registration: clinicaltrials.gov Identifier: NCT00153816.
Conflict of interest statement
Conflict of Interest Disclosures: Together with Dartmouth College, Dr Baron holds a patent for the chemopreventive use of calcium (US 6 251 439 B1). This is currently not licensed. No other disclosures are reported.
Figures
Figure
Study Enrollment and Randomization Flowchart
Similar articles
- Impact of Common Vitamin D-Binding Protein Isoforms on Supplemental Vitamin D3 and/or Calcium Effects on Colorectal Adenoma Recurrence Risk: A Secondary Analysis of a Randomized Clinical Trial.
Gibbs DC, Barry EL, Fedirko V, Baron JA, Bostick RM. Gibbs DC, et al. JAMA Oncol. 2023 Apr 1;9(4):546-551. doi: 10.1001/jamaoncol.2022.6924. JAMA Oncol. 2023. PMID: 36701139 Free PMC article. Clinical Trial. - Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA. Barry EL, et al. J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389. Epub 2014 Jul 29. J Clin Endocrinol Metab. 2014. PMID: 25070320 Free PMC article. Clinical Trial. - Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.
Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D. Grau MV, et al. J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71. doi: 10.1093/jnci/djg110. J Natl Cancer Inst. 2003. PMID: 14652238 Clinical Trial. - Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S. Bonovas S, et al. World J Gastroenterol. 2016 May 14;22(18):4594-603. doi: 10.3748/wjg.v22.i18.4594. World J Gastroenterol. 2016. PMID: 27182169 Free PMC article. Review. - Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P. Cooper K, et al. Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Health Technol Assess. 2010. PMID: 20594533 Review.
Cited by
- The Role of Dietary Vitamins and Antioxidants in Preventing Colorectal Cancer: A Systematic Review.
Ajebli M, Meretsky CR, Akdad M, Amssayef A, Hebi M. Ajebli M, et al. Cureus. 2024 Jul 10;16(7):e64277. doi: 10.7759/cureus.64277. eCollection 2024 Jul. Cureus. 2024. PMID: 39130946 Free PMC article. Review. - Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma.
Nakano S, Yamaji T, Hidaka A, Shimazu T, Shiraishi K, Kuchiba A, Saito M, Kunishima F, Nakaza R, Kohno T, Sawada N, Inoue M, Tsugane S, Iwasaki M. Nakano S, et al. J Gastroenterol. 2024 Sep;59(9):825-835. doi: 10.1007/s00535-024-02129-4. Epub 2024 Jun 20. J Gastroenterol. 2024. PMID: 38900300 - The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.
Smorodin E, Chuzmarov V, Veidebaum T. Smorodin E, et al. Curr Oncol. 2024 Apr 3;31(4):1994-2023. doi: 10.3390/curroncol31040149. Curr Oncol. 2024. PMID: 38668052 Free PMC article. Review. - Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B, Sajeev A, Vishwa R, Aswani BS, Alqahtani MS, Abbas M, Kunnumakkara AB. BharathwajChetty B, et al. Cancer Metastasis Rev. 2024 Mar;43(1):321-362. doi: 10.1007/s10555-024-10171-0. Epub 2024 Mar 22. Cancer Metastasis Rev. 2024. PMID: 38517618 Review. - Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis.
Ruan L. Ruan L. Medicine (Baltimore). 2024 Mar 1;103(9):e37361. doi: 10.1097/MD.0000000000037361. Medicine (Baltimore). 2024. PMID: 38428858 Free PMC article.
References
- Zhang X, Giovannucci E. Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract Res Clin Gastroenterol. 2011;25(4–5):485–494. - PubMed
- Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–357. - PubMed
- Pereira F, Larriba MJ, Muñoz A. Vitamin D and colon cancer. Endocr Relat Cancer. 2012;19(3):R51–R71. - PubMed
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. - PubMed
- Haussler MR, Whitfield GK, Kaneko I, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92(2):77–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA098286/CA/NCI NIH HHS/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- R03 CA159360/CA/NCI NIH HHS/United States
- P20 GM104416/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous